Navigation Links
New strategy likely to speed drug development for rare cancers
Date:9/15/2011

Researchers have identified promising new therapies for ependymoma, a rare tumor with few treatment options. St. Jude Children's Research Hospital investigators led the effort, which used a new, faster drug development system that combines the latest drug screening technology with the first accurate animal model of the tumor.

Investigators identified several dozen new and existing drugs as possible ependymoma treatment candidates. The drugs were found by screening 5,303 existing medicines, natural products and other compounds for activity against the tumor, which develops in the brain and spine of children and adults. The work is published in the current edition of the scientific journal Cancer Cell.

The list of candidate drugs included 5-fluorouracil (5-FU). 5-FU has been widely used to treat a variety of adult cancers but has not been formally tested against ependymoma. Based on study results, St. Jude is planning a clinical trial of 5-FU in young ependymoma patients, said senior author Richard Gilbertson, M.D., Ph.D., director of the St. Jude Comprehensive Cancer Center. Gilbertson credited the method used in this study with highlighting 5-FU's potential.

Researchers hope to use the same system to expand chemotherapy options for patients with other cancers. "This approach should significantly advance the efficiency and speed with which we discover and develop new treatments for rare cancers and cancer subtypes," the investigators noted. Jennifer Atkinson, Ph.D., a former St. Jude postdoctoral fellow, is the first author. R. Kiplin Guy, Ph.D., chair of the St. Jude Department of Chemical Biology and Therapeutics, and Gilbertson are corresponding authors.

Rather than waiting years for clinical trial results, this system promises to take just months to provide key information about a drug's effectiveness and optimal administration, Gilbertson said.

The results are good news for patients with ependymoma and ot
'/>"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-595-3061
St. Jude Children's Research Hospital
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study points to strategy for overcoming resistance to targeted cancer drug
2. Research identifies marketing mix strategy for pharmaceutical firms
3. New Strategy Trains All Soldiers in Trauma Care
4. NIH supports new research strategy for finding a cure for HIV
5. Coping Strategy Depends on Strength of Emotion: Study
6. Innovative duct tape strategy saves hospitals time, money; improves infection prevention
7. New strategy to attack tumor-feeding blood vessels
8. Researchers develop strategy to improve patient adherence
9. Potential new strategy to reduce catheter blockage
10. A Pacman strategy to boost the immune system to fight cancer
11. Scientists devise targeted therapy strategy for rare form of childhood cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ... June 29, 2015 , ... Scientists from the ... build nearly complete genomes by combining high-throughput DNA sequencing with genome mapping. The ... their association with human disease, but previously difficult to detect. The study was ...
(Date:6/29/2015)... ... June 29, 2015 , ... USA Today reported on ... Dakota, Arkansas, and Alabama. To impact the rest of the nation’s growing overdose death ... suggested the following guidelines be followed to stop the increasing overdose trend from continuing: ...
(Date:6/29/2015)... ... June 29, 2015 , ... New research ... fewer than 10 percent of U.S. state and local governments have implemented Next ... implementation deadline for NG9-1-1. , “Mobile phones have surpassed land lines as ...
(Date:6/29/2015)... ... June 29, 2015 , ... FACE is proud to be one ... the reduction of the double chin and redefining of the jawline. Excess fat ... much older and heavier causing the person distress and poor self-image. , Kybella was ...
(Date:6/29/2015)... , ... June 29, 2015 , ... Care to Care, ... to Care. , Dr. Faber will lead the Radiation Oncology Services Program, with a ... the use of Care to Care’s proprietary evidence based criteria. He will assist ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4Health News:Overdose Death Rates Decreased in Florida as of 2015 2Health News:Overdose Death Rates Decreased in Florida as of 2015 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 2Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 4Health News:FACE Detroit Skin and Wellness Clinic Introduces Newly FDA Approved Kybella for the elimination of the Double Chin. 2Health News:Care to Care, LLC Appoints a New Section Chief of Radiation Oncology 2Health News:Care to Care, LLC Appoints a New Section Chief of Radiation Oncology 3
... aerated beverages, yoga exponent Ramdev today asked the Centre ... that a statutory warning be written on every bottle ... a statutory warning should be written on every bottle ... infertility and diabetes,' he told reporters here., ,He ...
... Composite Laboratory at Kandaghat has not been functioning for over a ... since the former official for drug analyzing retired a month ago, ... his place. The number of samples awaiting testing at the laboratory ... Wasuja retired on April 30 after 38 years of service. With ...
... Goa, has suggested that the phar produce medicines which ... // He made this suggestion after inaugurating the new ... days ago. ,He also added that modern medicines and ... it was, therefore, essential that in the field of health ...
... High Court today held that medical colleges should give ... got caste validity certificate despite applying for the same. ... submit the certificate within 90 days of the admission, ... quotas, a candidate has to provide a caste certificate ...
... Australia could be receiving food supplements to improve their behaviour ... it is still investigating the feasibility of doing so. ... Department would review the British study, which claimed that children ... of Omega 3 fish oil. ,"The focus in ...
... Ramadoss Wednesday assured representatives of the civil society ... bring amendments in the legislation concerned to prevent ... willing to bring further amendments in the Preconception ... Act for stricter enforcement of the legislation," Ramadoss ...
Cached Medicine News:Health News:Working of Drug Department on Hold Without Drug Analyst 2
(Date:6/29/2015)... 2015 The global insulin market ... a new study by Grand View Research, Inc. Growing global prevalence ... high unmet needs in emerging markets such as India ... be two of the most significant growth drivers of this market. ... and growing global geriatric population base are expected to serve the ...
(Date:6/29/2015)... 29, 2015  VisionCare Ophthalmic Technologies, Inc. ... devices for the treatment of age-related macular ... "Long-Term (60-month) Results for the Implantable Miniature ... Age in Patients with End-Stage Age-Related Macular ... 5-year data show substantial retention of gains ...
(Date:6/29/2015)... Corporates today are on the ... CSR funds effectively.  A genuine step towards improving the ... would definitely interest them. And to make this possible, ... (MSC) to promote experiential learning.  STEM Learning is a ... India . So far, they have ...
Breaking Medicine Technology:Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 2Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 3Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 4Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 2Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 3Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 4Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 5Thinking of Innovative CSR Options? Partner With STEM Learning to Sponsor a Mini Science Centre 2Thinking of Innovative CSR Options? Partner With STEM Learning to Sponsor a Mini Science Centre 3
... $500 Million Senior Notes Offering in Connection With Agreement to... -- ARDEE, Ireland, Sept. 24 ... ... lpUnit=,PRN,; --> ... { var s = ,; var first_result; // Results are keyed by longUrl, so we need to ...
... 24 Stereotaxis, Inc. (Nasdaq: STXS ) today ... JMP Securities Healthcare Conference on Tuesday, September 28, 2010 at ... Officer, will provide an overview of the Company,s business strategy ... conference is by invitation only. A live audio and slides ...
Cached Medicine Technology:Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 2Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 3Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 4Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 5Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 6Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 7Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 8Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 9Stereotaxis to Present at the JMP Securities Healthcare Conference 2Stereotaxis to Present at the JMP Securities Healthcare Conference 3
... by seeing more patients per day. Utilizing the ... a 14-18 patients per day practice into a ... test sequences, youll perform accurate refractions in less ... making it easy to delegate tasks to office ...
... web-based application for secure access to ... reporting system. It is highly user ... comprehensive analysis, and professional reporting from ... with HIPAA requirements, reports also include ...
... Nothing can be more frustrating to a ... section of tissue than using instruments that are ... simple, or more complex, we offer a wide ... From realigning and polishing the tips to standard ...
... We repair most Olympus fiber and ... and intubation scopes used in OR and ... all repairs meet or exceed the standards ... with a 120-day warranty against defects in ...
Medicine Products: